| Literature DB >> 33001263 |
Felix Kleefeld1, Gabriele Arendt2, Eva Neuen-Jacob3, Matthias Maschke4, Ingo Husstedt5, Mark Obermann6, Holger Schmidt7, Katrin Hahn8.
Abstract
Chronic hepatitis C virus (HCV) infection is a highly prevalent systemic disease, which can cause a variety of neurological complications. The HCV-associated symptoms can be differentiated into central and peripheral nervous systems as well as the musculature. Important pathomechanisms are HCV-associated autoimmunity (e.g. mixed cryoglobulinemia with polyneuropathy) and direct neurotoxic effects of the virus (e.g. HCV-associated cognitive deficits). Distal symmetric polyneuropathies, small fiber neuropathies and cognitive deficits are the most prevalent neurological manifestations. Furthermore, HCV infection is a risk factor for ischemic and hemorrhagic stroke as well as Parkinson's disease. As HCV infection has become a permanently curable disease in >90% of patients, early identification and antiviral treatment of HCV positive patients is of utmost importance.Entities:
Keywords: Cognitive deficits; Cryoglobulinemia; Hepatitis C; Polyneuropathy; Small fiber neuropathy
Year: 2020 PMID: 33001263 DOI: 10.1007/s00115-020-00999-6
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214